A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
Clinical trial NCT06937229 · RECRUITING
Trial details
- NCT number
- NCT06937229
- Sponsor
- Bristol-Myers Squibb
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-02
- Primary completion
- 2029-06-22
- Enrollment
- 650
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.